Buscopan and Augmentin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Buscopan (hyoscine butylbromide) and Augmentin (amoxicillin; clavulanate potassium). Common drug interactions include haemorrhage among females and cerebellar infarction among males.

The phase IV clinical study analyzes what interactions people have when they take Buscopan and Augmentin. It is created by eHealthMe based on reports of 70 people who take the same drugs from the FDA, and is updated regularly.

What is Buscopan?

Buscopan has active ingredients of hyoscine butylbromide. eHealthMe is studying from 4,828 Buscopan users. Check the latest studies of Buscopan.

What is Augmentin?

Augmentin has active ingredients of amoxicillin; clavulanate potassium. It is often used in sinusitis. eHealthMe is studying from 42,620 Augmentin users. Check the latest studies of Augmentin.



On Jul, 19, 2026

70 people who take Buscopan and Augmentin together, and have interactions are studied.

Buscopan and Augmentin drug interactions.

What are the common drug interactions of Buscopan and Augmentin, by gender? *:

female:

  1. Haemorrhage (bleeding)
  2. Leukopenia (less number of white blood cells in blood)
  3. Haematochezia (passage of stools containing blood)
  4. Aortic rupture
  5. Contusion (a type of hematoma of tissue in which capillaries)
  6. Dehydration (dryness resulting from the removal of water)
  7. Fatigue (feeling of tiredness)
  8. Hepatitis acute
  9. Hypokalaemia (low potassium)
  10. Intestinal ischaemia (decreased supply of oxygenated blood to the intestines)

male:

  1. Cerebellar infarction (impaired blood circulation to cerebellum)
  2. Cough
  3. Blood creatinine increased
  4. Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
  5. Dyspnoea (difficult or laboured respiration)
  6. Foetal exposure during pregnancy (exposing your unborn child to contraindicated in pregnancy leads birth defect)
  7. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  8. Haemangioma (noncancerous, abnormally dense collections of dilated small blood vessels that may occur in the skin or internal organs)
  9. Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
  10. Hypoxia (low oxygen in tissues)

What are the common drug interactions of Buscopan and Augmentin, by age (0-1 to 60+)? *:

0-1:

  1. Abdominal pain
  2. Cough
  3. Foetal exposure during pregnancy (exposing your unborn child to contraindicated in pregnancy leads birth defect)
  4. Haemangioma (noncancerous, abnormally dense collections of dilated small blood vessels that may occur in the skin or internal organs)
  5. Influenza
  6. Otitis media (inflammation of the middle ear)
  7. Pyrexia (fever)
  8. Thermal burn (burn by heat)
  9. Upper respiratory tract infection
  10. Viral upper respiratory tract infection

2-9:

n/a

10-19:

  1. Alveolitis (inflammation in the socket of a tooth)
  2. Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
  3. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  4. Cough
  5. Dyspnoea (difficult or laboured respiration)
  6. Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
  7. Hypoxia (low oxygen in tissues)
  8. Respiratory distress (difficulty in breathing)
  9. Malignant neoplasm progression (cancer tumour came back)
  10. Partial seizures (seizures which affect only a part of the brain at onset)

20-29:

  1. Hepatitis acute
  2. Cough
  3. Fatigue (feeling of tiredness)
  4. Abdominal pain
  5. Anal ulcer
  6. Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
  7. Blood creatinine increased
  8. Blood urea increased
  9. Coma (state of unconsciousness lasting more than six hours)
  10. Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it)

30-39:

  1. Abdominal pain upper
  2. Abortion spontaneous (naturally occurring miscarriage)
  3. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  4. Dermatitis acneiform (dermatoses including acne vulgaris, rosacea, folliculitis, and perioral dermatitis)
  5. Drug specific antibody present
  6. Foetal death (death of foetus)
  7. Gallbladder disorder
  8. Inflammatory marker increased
  9. Intestinal resection

40-49:

  1. Large intestine perforation (hole in large intestine)
  2. Malaise (a feeling of general discomfort or uneasiness)
  3. Pneumonia
  4. Red blood cell count decreased
  5. Small intestine carcinoma (cancer tumour of small intestine)
  6. Vomiting
  7. Cerebellar infarction (impaired blood circulation to cerebellum)
  8. Abdominal pain
  9. Bladder spasm
  10. Blood alkaline phosphatase increased

50-59:

  1. Abscess (pus)
  2. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  3. Ileus (a painful obstruction of the ileum or other part of the intestine)
  4. Malignant neoplasm progression (cancer tumour came back)
  5. Abdominal pain upper
  6. Ascites (accumulation of fluid in the abdominal cavity)
  7. Constipation
  8. Decreased appetite
  9. Dry eye (lack of adequate tears)
  10. Fatigue (feeling of tiredness)

60+:

  1. Death
  2. Febrile neutropenia (fever with reduced white blood cells)
  3. Post procedural haemorrhage (post procedural bleeding)
  4. Rectal ulcer (ulcer of rectum)
  5. Wound infection
  6. Blood sodium decreased
  7. Haematochezia (passage of stools containing blood)
  8. Malignant neoplasm progression (cancer tumour came back)
  9. Respiratory failure (inadequate gas exchange by the respiratory system)
  10. Sepsis (a severe blood infection that can lead to organ failure and death)

What are the existing conditions these people have? *

  1. Nausea (feeling of having an urge to vomit): 19 people, 27.14%
  2. Abdominal Pain: 18 people, 25.71%
  3. High Blood Pressure: 13 people, 18.57%
  4. Constipation: 13 people, 18.57%
  5. Diarrhea: 13 people, 18.57%
  6. Pain: 12 people, 17.14%
  7. Chest Pain: 11 people, 15.71%
  8. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 11 people, 15.71%
  9. Anaemia (lack of blood): 10 people, 14.29%
  10. Abdominal Pain Upper: 9 people, 12.86%

* Approximation only. Some reports may have incomplete information.

Do you take Buscopan and Augmentin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Buscopan and Augmentin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Buscopan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Augmentin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Buscopan and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Augmentin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on hyoscine butylbromide and amoxicillin; clavulanate potassium (the active ingredients of Buscopan and Augmentin, respectively), and Buscopan and Augmentin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: